All In Biotech

Drug Trial Radar · NCT06662773

Drug-Drug Interaction (DDI) Study for TQB3616

Phase I Clinical Trial Evaluating Drug Drug Interactions of TQB3616 Capsules

Last checked: Nov 19, 2026Latest source record: Oct 29, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

40

Planned (sponsor's estimate)

Start

Nov 2024

Primary completion

Mar 2025

Study completion Jul 2025

Sponsor

Sponsor type
Industry
First posted
Oct 29, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To evaluate the effect of itraconazole/rifampicin on the pharmacokinetics of TQB3616 capsules. To assess the safety of a single dose of oral TQB3616 capsules and in combination with itraconazole/rifampicin.

Conditions

  • Healthy

Interventions

  • TQB3616 capsule + itraconazoleDrug

    C2/4/6 inhibitors + CYP3A metabolic enzyme inhibitors

  • TQB3616 capsule + rifampicinDrug

    C2/4/6 inhibitors + Non-specific cytochrome P450 enzyme inducer

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Peak concentration (Cmax)Time frame: Before administration, 1,2,4,6,8,12,24,48,72,120,168,216 hours after administration
  2. Area under drug time curve (AUC0-t)Time frame: Before administration, 1,2,4,6,8,12,24,48,72,120,168,216 hours after administration
  3. Area under drug time curve (AUC0-∞)Time frame: Before administration, 1,2,4,6,8,12,24,48,72,120,168,216 hours after administration

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Beijing Tongren Hospital Affiliated to Capital Medical University

    Beijing, Beijing Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.